We are live on
!
Find out more
NAMI
Nomura Asset Management International Portfolio holdings
AUM
$66.6B
This Fund
S&P 500
This Quarter
Est. Return
+24.24%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.6B
AUM Growth
+$8.21B
(+14%)
Cap. Flow
-$1.23B
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
21.73%
Holding
1,429
New
172
Increased
379
Reduced
546
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$501M |
| 2 |
Apple
AAPL
|
+$428M |
| 3 |
Eli Lilly
LLY
|
+$390M |
| 4 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$208M |
| 5 |
SPCX
SpaceX
SPCX
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seagate
STX
|
+$1.37B |
| 2 |
Micron Technology
MU
|
+$414M |
| 3 |
Semtech
SMTC
|
+$199M |
| 4 |
Meta Platforms (Facebook)
META
|
+$175M |
| 5 |
Intuit
INTU
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.38% |
| 2 | Financials | 12.87% |
| 3 | Industrials | 12.33% |
| 4 | Healthcare | 10.94% |
| 5 | Consumer Discretionary | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Eversource Energy
ES
$26.4B
| $387K | ﹤0.01% |
+5,359
| New | +$371K |
|
1227
Instil Bio
TIL
$51.4M
| $385K | ﹤0.01% |
50,000
| – | – |
|
1228
Sabesp
SBS
$16.2B
| $380K | ﹤0.01% |
+65,662
| New | +$398K |
|
1229
NCR Atleos
NATL
$3.43B
| $378K | ﹤0.01% |
8,700
-19,500
| -69% | -$865K |
|
1230
PayPal
PYPL
$52.7B
| $372K | ﹤0.01% |
+8,624
| New | +$392K |
|
1231
American Eagle Outfitters
AEO
$2.71B
| $363K | ﹤0.01% |
21,100
-6,510
| -24% | -$113K |
|
1232
Wheaton Precious Metals
WPM
$71.7B
| $360K | ﹤0.01% |
3,206
-2,478
| -44% | -$322K |
|
1233
Intellia Therapeutics
NTLA
$1.8B
| $338K | ﹤0.01% |
20,000
| – | – |
|
1234
Baker Hughes
BKR
$61.9B
| $328K | ﹤0.01% |
5,911
-14,670
| -71% | -$927K |
|
1235
Atea Pharmaceuticals
AVIR
$436M
| $326K | ﹤0.01% |
70,000
| – | – |
|
1236
Karyopharm Therapeutics
KPTI
$44.5M
| $326K | ﹤0.01% |
+33,333
| New | +$289K |
|
1237
Allogene Therapeutics
ALLO
$722M
| $305K | ﹤0.01% |
146,779
| – | – |
|
1238
Altimmune
ALT
$605M
| $304K | ﹤0.01% |
100,000
| – | – |
|
1239
International Flavors & Fragrances
IFF
$21.5B
| $299K | ﹤0.01% |
+3,773
| New | +$281K |
|
1240
Fortinet
FTNT
$113B
| $292K | ﹤0.01% |
1,903
-2,560
| -57% | -$296K |
|
1241
Costamare
CMRE
$1.89B
| $289K | ﹤0.01% |
20,632
| – | – |
|
1242
Myriad Genetics
MYGN
$306M
| $286K | ﹤0.01% |
50,000
| – | – |
|
1243
CenterPoint Energy
CNP
$25.5B
| $281K | ﹤0.01% |
+6,382
| New | +$273K |
|
1244
AerCap
AER
$23B
| $280K | ﹤0.01% |
+1,922
| New | +$273K |
|
1245
Ball Corp
BALL
$16.8B
| $278K | ﹤0.01% |
4,453
-61,317
| -93% | -$3.6M |
|
1246
FirstEnergy
FE
$26.6B
| $258K | ﹤0.01% |
+5,429
| New | +$258K |
|
1247
Hyatt Hotels
H
$17B
| $251K | ﹤0.01% |
1,294
-32,150
| -96% | -$5.63M |
|
1248
Metallus
MTUS
$812M
| $251K | ﹤0.01% |
13,431
-12,090
| -47% | -$227K |
|
1249
Charles River Laboratories
CRL
$14.1B
| $249K | ﹤0.01% |
+1,100
| New | +$196K |
|
1250
Equitable Holdings
EQH
$13.3B
| $238K | ﹤0.01% |
5,435
-10,965
| -67% | -$458K |
|
Similar funds
Nomura Asset Management International's Q2 2026 Portfolio in Review
As of Q2 2026, Nomura Asset Management International held 1,429 positions worth $66.6B, up 14% from $58.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nomura Asset Management International's Q2 2026 filing shows 172 new, 379 increased, 546 reduced and 103 closed positions. Its largest new stake was Vanguard Russell 1000 Growth ETF: 1,674,624 shares worth $214M. The largest sale was Seagate, an estimated $1.37B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- Nomura Asset Management International's largest Q2 2026 buy was Vanguard Russell 1000 Growth ETF: 1,674,624 shares worth $214M.
- Nomura Asset Management International added most to Lam Research in Q2 2026, an estimated $501M increase.
- Nomura Asset Management International's biggest Q2 2026 reduction was Seagate, cutting an estimated $1.37B.
- Nomura Asset Management International fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $127M.
- Nomura Asset Management International's ten largest holdings make up 22% of its $66.6B portfolio in Q2 2026.
- Nomura Asset Management International opened 172 new positions and closed 103 in Q2 2026.
- Nomura Asset Management International's portfolio value rose 14% quarter-over-quarter to $66.6B.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.